Shares of Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) saw strong trading volume on Thursday. 6,357 shares changed hands during trading, an increase of 777% from the previous session’s volume of 725 shares. The stock last traded at $46.90 and had previously closed at $45.77.
Orion OYJ Stock Down 2.3%
The company has a quick ratio of 1.48, a current ratio of 2.64 and a debt-to-equity ratio of 0.08. The business has a fifty day simple moving average of $45.35 and a two-hundred day simple moving average of $41.10. The company has a market capitalization of $12.96 billion, a price-to-earnings ratio of 18.89 and a beta of 0.07.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last released its quarterly earnings results on Friday, July 17th. The company reported $0.58 earnings per share for the quarter. The firm had revenue of $606.38 million during the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.
About Orion OYJ
Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.
The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas.
See Also
- Five stocks we like better than Orion OYJ
- MarketBeat Week in Review – 10/05 – 10/09
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
